![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 35/761 |
(11) | Number of the document | 3007711 |
(13) | Kind of document | T |
(96) | European patent application number | 14736650.4 |
Date of filing the European patent application | 2014-06-12 | |
(97) | Date of publication of the European application | 2016-04-20 |
(45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2014/062284 |
Date | 2014-06-12 |
(87) | Number | WO 2014/198852 |
Date | 2014-12-18 |
(30) | Number | Date | Country code |
201310698 | 2013-06-14 | GB | |
201405140 | 2014-03-22 | GB | |
201406509 | 2014-04-10 | GB |
(72) |
BEADLE, John, William, GB
FISHER, Kerry, GB
WILKINSON BLANC, Christine, GB
|
(73) |
Psioxus Therapeutics Limited,
154B Milton Park, Abingdon, Oxfordshire OX14 4SD,
GB
|
(54) | A DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES |
A DOSING REGIME AND FORMULATIONS FOR TYPE B ADENOVIRUSES |